SOLACI PERIPHERAL | 2nd Clinical Case: Juxtarenal Abdominal Aortic Aneurysm

Discusión de caso clínico

SOLACI’s Department of Peripheral Endovascular Interventions brings a new challenging clinical case for the whole Latin American medical community so as to continue fostering and sharing scientific knowledge and experience among peers.

Tell us what you think about this case and its resolution using the comments section in this post, and answer the questions featured in the last part of this article.


Juxtarenal Abdominal Aortic Aneurysm


Authors: Dr. Luis R. Virgen Carrillo, MD, PhD / Dr. Carlos Salazar, MD / Dr. Rodolfo Siordia Zamorano, MD.

E-mail: drvirgen@cardiovascular.mx; Twitter: @drluisvirgen

Institution: Virgen Cardiovascular Research, Guadalajara, Mexico, & Cirujanos Cardiovasculares del Noroeste.


– Male patient, 61 years old, anesthesiologist, cigarette smoker, hypertensive. He begins experiencing intense abdominal pain. Hb reduction, 14-11 g/dL. He is hemodynamically stable; blood pressure 110/60 mmHg, heart rate 68 bpm. An abdominal computed tomography angiography shows the contained rupture of an abdominal aneurysm. Anatomy: juxtarenal aneurysm without neck, with small, tortuous iliac arteries.

Caso SOLACI PERIPHERAL - Aneurisma de Aorta Abdominal Yuxtarrenal


Case Resolution

– The algorithm for the attention of patients with suspected abdominal aneurysm rupture is activated. Physicians choose a percutaneous endovascular treatment (the chimney technique [chEVAR]).

Caso Clínico SOLACI Peripheral

– The procedure is conducted in a hybrid cath lab; bilateral femoral artery puncture, guided by ultrasound and image fusion. Two Perclose devices are used in each femoral artery. Both brachial arteries are dissected; an 8-Fr flexor introducer sheath is placed inside each renal artery. Selective renal artery catheterization and stenting using an 8×39 film-coated BeGraft (Bentley Innomed GmbH, Hechingen, Germany). A parallel 0.035” Magic Torque guidewire ×260 cm is used. Then, an Ovation 26 Abdominal Stent Graft System (Endologix, California, USA), 14-15 Fr OD, is used. The device is placed using image fusion, the fill polymer is delivered, and both BeGraft stents are implanted. After the procedure, there is a type Ia endoleak in peri-chimney spaces (“gutters”). New dilation conducted with partial improvement. A decision is made to conduct an embolization with an Onix device at a second instance.

– The patient is stable and does not experience pain. An ultrasound is conducted within 24 hours: no flow in the aneurysm sac.

2° Caso SOLACI Peripheral Aneurisma de aorta abdominal yuxtarrenal

– A computed tomography angiography is conducted at 72 hours, 1, 6, and 12 months; no endoleaks. (VIDEO #2)


Questions

  1. Is there an algorithm for the attention of patients with suspected abdominal aneurysm rupture at your site?
  2. In your opinion, what is the best option for a patient with aneurysm rupture: surgical treatment or endovascular treatment?
  3. What is your treatment of choice for para/juxtarenal aneurysms?
  4. Should type I endoleaks be treated in the cath lab?

Join the conversation through the comments in this post!


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Transcatheter Pulmonary Valve Implantation with a Self-Expanding Valve: Outcomes at 3 Years

Pulmonary regurgitation (PR) is a common condition in patients who have undergone surgical repair of Tetralogy of Fallot or other pathologies involving the right...

How to apply for the SOLACI Research 2025 Grant? Step-by-step explanation video

You can now rewatch the virtual event we held on April 9th, where we thoroughly reviewed the steps to apply for the SOLACI Research...

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

April 9 – How to Apply for the SOLACI Research Grant 2025? Virtual Zoom Event

The Latin American Society of Interventional Cardiology invites you to a new virtual event hosted by the SOLACI Research Department, aimed at clarifying doubts,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...